TipRanks
Kwang Dong Pharmaceutical Co., Ltd. (KR:009290)
:009290
South Korea Market
009290
Kwang Dong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Kwang Dong Pharmaceutical Co., Ltd. (009290) Ratios

― Followers

Kwang Dong Pharmaceutical Co., Ltd. Ratios

KR:009290's free cash flow for Q2 2026 was ₩0.17. For the 2026 fiscal year, KR:009290's free cash flow was decreased by ₩ and operating cash flow was ₩<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.34 1.36 1.56 1.46 1.71
Quick Ratio
 0.92 0.98 1.09 1.04 1.26
Cash Ratio
 0.17 0.27 0.25 0.17 0.29
Solvency Ratio
 0.07 0.06 0.10 0.10 0.10
Operating Cash Flow Ratio
 0.03 0.16 -0.03 -0.03 0.18
Short-Term Operating Cash Flow Coverage
 0.08 0.36 -0.06 -0.06 0.56
Net Current Asset Value
₩ 100.34B₩ 112.08B₩ 167.10B₩ 175.41B₩ 220.77B
Leverage Ratios
Debt-to-Assets Ratio
 0.23 0.23 0.24 0.22 0.15
Debt-to-Equity Ratio
 0.47 0.46 0.49 0.43 0.27
Debt-to-Capital Ratio
 0.32 0.32 0.33 0.30 0.21
Long-Term Debt-to-Capital Ratio
 0.08 0.08 0.10 0.03 0.04
Financial Leverage Ratio
 2.05 2.01 2.02 1.98 1.80
Debt Service Coverage Ratio
 -0.10 0.16 0.13 0.21 0.38
Interest Coverage Ratio
 2.95 2.82 2.93 7.06 10.24
Debt to Market Cap
 0.90 0.93 1.28 0.76 0.56
Interest Debt Per Share
 5.37K 5.99K 7.40K 5.99K 3.45K
Net Debt to EBITDA
 -14.46 3.34 3.80 2.88 0.64
Profitability Margins
Gross Profit Margin
17.61%17.67%18.24%19.49%19.70%
EBIT Margin
-2.02%1.87%1.83%2.78%2.80%
EBITDA Margin
-0.87%2.92%2.72%3.63%3.77%
Operating Profit Margin
1.96%1.87%1.83%3.22%2.67%
Pretax Profit Margin
1.93%1.87%3.49%3.24%2.54%
Net Profit Margin
1.28%1.26%2.47%2.44%1.69%
Continuous Operations Profit Margin
1.34%1.29%2.55%2.60%1.87%
Net Income Per EBT
66.31%67.67%70.62%75.41%66.61%
EBT Per EBIT
98.12%99.80%190.46%100.52%94.89%
Return on Assets (ROA)
1.67%1.59%3.46%3.43%2.59%
Return on Equity (ROE)
3.45%3.20%6.99%6.79%4.67%
Return on Capital Employed (ROCE)
4.27%3.91%4.25%7.85%6.61%
Return on Invested Capital (ROIC)
2.28%2.07%2.38%4.69%4.06%
Return on Tangible Assets
1.74%1.65%3.57%3.55%2.64%
Earnings Yield
5.94%6.83%18.59%12.10%10.04%
Efficiency Ratios
Receivables Turnover
 5.74 5.91 5.23 5.90 6.29
Payables Turnover
 6.71 7.11 7.90 7.13 6.60
Inventory Turnover
 6.44 6.71 6.17 6.46 7.12
Fixed Asset Turnover
 6.53 6.16 6.59 7.13 9.32
Asset Turnover
 1.30 1.26 1.40 1.40 1.54
Working Capital Turnover Ratio
 10.15 7.38 7.04 6.57 5.56
Cash Conversion Cycle
 65.93 64.82 82.70 67.16 54.03
Days of Sales Outstanding
 63.64 61.79 69.79 61.90 58.04
Days of Inventory Outstanding
 56.69 54.38 59.11 56.47 51.25
Days of Payables Outstanding
 54.40 51.35 46.20 51.20 55.27
Operating Cycle
 120.33 116.17 128.90 118.37 109.29
Cash Flow Ratios
Operating Cash Flow Per Share
 303.96 1.57K -303.63 -289.85 1.53K
Free Cash Flow Per Share
 74.67 1.09K -2.25K -1.16K 895.37
CapEx Per Share
 229.29 481.26 1.94K 868.73 633.85
Free Cash Flow to Operating Cash Flow
 0.25 0.69 7.40 4.00 0.59
Dividend Paid and CapEx Coverage Ratio
 0.97 2.82 -0.15 -0.30 2.08
Capital Expenditure Coverage Ratio
 1.33 3.26 -0.16 -0.33 2.41
Operating Cash Flow Coverage Ratio
 0.06 0.27 -0.04 -0.05 0.46
Operating Cash Flow to Sales Ratio
 0.01 0.05 >-0.01 >-0.01 0.04
Free Cash Flow Yield
1.39%18.59%-41.31%-15.35%15.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.66 11.25 5.39 8.27 9.96
Price-to-Sales (P/S) Ratio
 0.19 0.19 0.13 0.20 0.17
Price-to-Book (P/B) Ratio
 0.58 0.47 0.38 0.56 0.47
Price-to-Free Cash Flow (P/FCF) Ratio
 73.16 5.38 -2.42 -6.52 6.54
Price-to-Operating Cash Flow Ratio
 21.06 3.73 -17.92 -26.05 3.83
Price-to-Earnings Growth (PEG) Ratio
 -0.49 -0.23 0.51 0.15 15.44
Price-to-Fair Value
 0.58 0.47 0.38 0.56 0.47
Enterprise Value Multiple
 -35.97 9.67 8.68 8.44 5.10
Enterprise Value
 526.89B 469.40B 387.48B 463.85B 275.19B
EV to EBITDA
 -35.67 9.67 8.68 8.44 5.10
EV to Sales
 0.31 0.28 0.24 0.31 0.19
EV to Free Cash Flow
 121.28 8.22 -4.31 -9.89 7.48
EV to Operating Cash Flow
 29.79 5.70 -31.88 -39.54 4.38
Tangible Book Value Per Share
 11.18K 12.70K 14.51K 13.62K 12.92K
Shareholders’ Equity Per Share
 10.98K 12.51K 14.47K 13.46K 12.59K
Tax and Other Ratios
Effective Tax Rate
 0.30 0.31 0.27 0.20 0.26
Revenue Per Share
 29.34K 31.66K 40.99K 37.42K 34.85K
Net Income Per Share
 375.05 400.00 1.01K 913.38 588.45
Tax Burden
 0.66 0.68 0.71 0.75 0.67
Interest Burden
 -0.96 1.00 1.90 1.17 0.91
Research & Development to Revenue
 <0.01 <0.01 <0.01 0.01 <0.01
SG&A to Revenue
 0.09 0.09 0.09 0.15 0.10
Stock-Based Compensation to Revenue
 <0.01 0.00 0.00 0.00 0.00
Income Quality
 0.80 3.93 -0.29 -0.30 2.35
Currency in KRW